Member Events Calendar

 
 
 
 
Loading Events

« All Events

  • This event has passed.

NCCN PHARMACY UPDATES: CROSSROADS OF EXERCISE AND CHEMOTHERAPY

March 10 @ 1:00 pm

Exercise and nutrition may be only briefly discussed during treatment planning, and patients may be unwilling to consider exercise during chemotherapy.  It is important to provide education and an action plan to outline how exercise may not only reduce side effects from chemotherapy but also help chemotherapy work better and improve survival.  As new data emerges, more specific exercise “doses” can be prescribed.

TARGET AUDIENCE

This program is designed to meet the educational needs of pharmacists, physicians, nurses, nurse practitioners, physician assistants and other health care professionals who manage patients with cancer.

LEARNING OBJECTIVES

Following this activity, participants should be able to:

  • Summarize the history of and describe the future directions for exercise oncology.
  • Explain how exercise may improve the effectiveness of chemotherapy through alterations in the tumor microenvironment and how exercise mitigates side effects of chemotherapy.
  • Design an exercise plan to incorporate into drug counseling.
ADDITIONAL INFORMATION
SUPPORTERS:

This activity is supported by educational grants from:

  • AstraZeneca
  • Bayer HealthCare Pharmaceuticals Inc.
  • Daiichi Sankyo
  • Epizyme Inc.
  • Novartis
  • Sanofi Genzyme

This activity is supported through independent medical education grants from:

  • Merck & Co., Inc.
  • Regeneron Pharmaceuticals, Inc and Sanofi Genzyme

This activity is supported by an education grant from Seagen Inc. formerly Seattle Genetics.

Register here: https://education.nccn.org/node/91437#group-tabs-node-course-default4

Details

Date:
March 10
Time:
1:00 pm
Stay in the Know
Read Latest News